Satellite Symposium at the Congress of the International Academy of Pathology
CD30 detection in haematological malignancies: diagnosis and therapeutics
7 October 2014 12:00-13:30
Bangkok Convention Centre at CentralWorld, Bangkok, Thailand
Lotus 1-4
LEARNING OBJECTIVES:

After having participated in the satellite symposium, the pathologist will:

  1. Understand the importance of CD30 detection in diagnosis and treatment
  2. Apply the best practice to detect CD30 in malignant tissues, recognize the pitfalls in CD30 detection and potential solutions
  3. Evaluate recent data from clinical trials using CD30-targeting therapeutics on relapsed/refractory HL and sALCL, which focuses on brentuximab vedotin, and outline the clinical relevance for other haematological malignancies

PROGRAMME:

12:00-12:05 Welcome and introduction (Prof. Pileri)

12:05-12:15 CD30 staining: getting the results right (Prof. Pileri)

12:15-12:30 The need for CD30 detection: a haematologist’s perspective (Prof. Yok Lam Kwong)

12:30-12:50 The challenges of CD30 detection: interactive case study 1 (Dr. Tan)

12:50-13:10 The challenges of CD30 detection: interactive case study 2 (Prof. Oshima)

13:10-13:25 Panel discussion and Q&A (All faculty)

13:25-13:30 Closing (Prof. Pileri)

Chair:

Stefano Pileri
Italy
Faculty:

Koichi Ohshima
Japan

Leonard Hwan Cheong Tan
Singapore

Yok Lam Kwong
This meeting is an
Excerpta Medica activity.
logos
Support for this educational activity is provided by
Takeda Oncology.
logos